<?xml version="1.0" encoding="UTF-8" ?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="en-US"><title type="html">strandls</title><subtitle type="html" /><id>http://bioitalliance.org/blogs/strandls/atom.aspx</id><link rel="alternate" type="text/html" href="http://bioitalliance.org/blogs/strandls/default.aspx" /><link rel="self" type="application/atom+xml" href="http://bioitalliance.org/blogs/strandls/atom.aspx" /><generator uri="http://communityserver.org" version="2.0.60217.2664">Community Server</generator><updated>2006-10-03T04:59:00Z</updated><entry><title>Strand Launches Sarchitect for in-silico Lead Optimization </title><link rel="alternate" type="text/html" href="http://bioitalliance.org/blogs/strandls/archive/2007/04/02/153.aspx" /><link rel="enclosure" type="application/pdf" length="68754" href="http://www.strandls.com/files/Sarchitect_launch_press_release.pdf" /><id>http://bioitalliance.org/blogs/strandls/archive/2007/04/02/153.aspx</id><published>2007-04-02T06:18:00Z</published><updated>2007-04-02T06:18:00Z</updated><content type="html">&lt;P class=MsoNormal&gt;&lt;SPAN&gt;&lt;FONT face=Arial&gt;Strand Life Sciences announces the launch of its SAR modelling and deployment platform – Sarchitect.&lt;SPAN&gt;&amp;nbsp; &lt;/SPAN&gt;Sarchitect addresses the challenge of taking the model building prowess of computational chemists through to decision support in medicinal chemistry. Gilead Sciences, Inc. has signed on as the first customer of Sarchitect.&lt;o:p&gt;&lt;/o:p&gt;&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;img src="http://bioitalliance.org/aggbug.aspx?PostID=153" width="1" height="1"&gt;</content><author><name>strandls</name><uri>http://bioitalliance.org/members/strandls.aspx</uri></author></entry><entry><title>Strand named Technology Pioneer 2007 by World Economic Forum</title><link rel="alternate" type="text/html" href="http://bioitalliance.org/blogs/strandls/archive/2006/12/06/84.aspx" /><link rel="enclosure" type="application/pdf" length="160058" href="http://www.strandls.com/files/press_release_for_Tech_Pioneer_2007.pdf" /><id>http://bioitalliance.org/blogs/strandls/archive/2006/12/06/84.aspx</id><published>2006-12-06T13:47:00Z</published><updated>2006-12-06T13:47:00Z</updated><content type="html">Press Release announcing Strand's selection as Technology Pioneer 2007 by the World Economic Forum on December 4, 2006....(&lt;a href="http://bioitalliance.orghttp://bioitalliance.org/blogs/strandls/archive/2006/12/06/84.aspx"&gt;read more&lt;/a&gt;)&lt;img src="http://bioitalliance.org/aggbug.aspx?PostID=84" width="1" height="1"&gt;</content><author><name>strandls</name><uri>http://bioitalliance.org/members/strandls.aspx</uri></author></entry><entry><title>Strand Joins Microsoft Promoted BioIT Alliance</title><link rel="alternate" type="text/html" href="http://bioitalliance.org/blogs/strandls/archive/2006/10/18/70.aspx" /><link rel="enclosure" type="application/pdf" length="26986" href="http://www.strandls.com/files/press_bioitalliance.pdf" /><id>http://bioitalliance.org/blogs/strandls/archive/2006/10/18/70.aspx</id><published>2006-10-18T01:52:00Z</published><updated>2006-10-18T01:52:00Z</updated><content type="html">
Strand Life Sciences, a Bangalore-based life sciences informatics company announced today
that it has joined the BioIT Alliance formed by Microsoft....(&lt;a href="http://bioitalliance.orghttp://bioitalliance.org/blogs/strandls/archive/2006/10/18/70.aspx"&gt;read more&lt;/a&gt;)&lt;img src="http://bioitalliance.org/aggbug.aspx?PostID=70" width="1" height="1"&gt;</content><author><name>strandls</name><uri>http://bioitalliance.org/members/strandls.aspx</uri></author></entry><entry><title>Strand joins Microsoft's BioIT Alliance</title><link rel="alternate" type="text/html" href="http://bioitalliance.org/blogs/strandls/archive/2006/10/17/56.aspx" /><link rel="enclosure" type="application/pdf" length="26986" href="http://bioitalliance.org/blogs/files/24/56/press_bioitalliance.pdf" /><id>http://bioitalliance.org/blogs/strandls/archive/2006/10/17/56.aspx</id><published>2006-10-17T01:09:00Z</published><updated>2006-10-17T01:09:00Z</updated><content type="html">&lt;P&gt;Bangalore, India | October 17, 2006&lt;/P&gt;
&lt;P&gt;Strand Life Sciences becomes a member of the BioIT Alliance.&lt;/P&gt;&lt;img src="http://bioitalliance.org/aggbug.aspx?PostID=56" width="1" height="1"&gt;</content><author><name>strandls</name><uri>http://bioitalliance.org/members/strandls.aspx</uri></author></entry><entry><title>Strand-Stratagene White Papers Series - Grammatica: The PathwayArchitect NLP Engine</title><link rel="alternate" type="text/html" href="http://bioitalliance.org/blogs/strandls/archive/2006/10/03/33.aspx" /><link rel="enclosure" type="application/pdf" length="188568" href="http://www.strandls.com/files/nlp.pdf" /><id>http://bioitalliance.org/blogs/strandls/archive/2006/10/03/33.aspx</id><published>2006-10-03T07:27:00Z</published><updated>2006-10-03T07:27:00Z</updated><content type="html">&lt;FONT face=Arial&gt;&lt;FONT face=Courier&gt;
&lt;P align=left&gt;&lt;FONT face=Arial size=2&gt;An innovative solution from Strand-Stratagene to design fully automated natural language processing systems that can extract biological interactions from literature&lt;/FONT&gt;&lt;/FONT&gt;&lt;FONT size=2&gt;.&lt;/FONT&gt;&lt;/P&gt;&lt;/FONT&gt;&lt;img src="http://bioitalliance.org/aggbug.aspx?PostID=33" width="1" height="1"&gt;</content><author><name>strandls</name><uri>http://bioitalliance.org/members/strandls.aspx</uri></author></entry><entry><title>Case Study - Classification in avadis</title><link rel="alternate" type="text/html" href="http://bioitalliance.org/blogs/strandls/archive/2006/10/03/32.aspx" /><link rel="enclosure" type="application/pdf" length="1311415" href="http://www.strandls.com/files/avadis_classification.pdf" /><id>http://bioitalliance.org/blogs/strandls/archive/2006/10/03/32.aspx</id><published>2006-10-03T07:24:00Z</published><updated>2006-10-03T07:24:00Z</updated><content type="html">&lt;TABLE cellSpacing=0 cellPadding=5&gt;

&lt;TR&gt;
&lt;TD class=resrs-td3-bgclr&gt;&lt;/TD&gt;
&lt;TD&gt;
&lt;P&gt;&lt;FONT face=Arial size=2&gt;Analysis of classification and prediction algorithms in avadis 2.0 on the Lymphoma dataset.&lt;/FONT&gt;&lt;/P&gt;&lt;/TD&gt;&lt;/TR&gt;&lt;/TABLE&gt;&lt;img src="http://bioitalliance.org/aggbug.aspx?PostID=32" width="1" height="1"&gt;</content><author><name>strandls</name><uri>http://bioitalliance.org/members/strandls.aspx</uri></author></entry><entry><title>Case Study - Clustering in avadis</title><link rel="alternate" type="text/html" href="http://bioitalliance.org/blogs/strandls/archive/2006/10/03/31.aspx" /><link rel="enclosure" type="application/pdf" length="901917" href="http://www.strandls.com/files/avadis_clustering.pdf" /><id>http://bioitalliance.org/blogs/strandls/archive/2006/10/03/31.aspx</id><published>2006-10-03T07:21:00Z</published><updated>2006-10-03T07:21:00Z</updated><content type="html">&lt;P&gt;&lt;FONT face=Arial size=2&gt;Comparative analysis of clustering results on the Diauxic dataset.&lt;/FONT&gt;&lt;/P&gt;&lt;img src="http://bioitalliance.org/aggbug.aspx?PostID=31" width="1" height="1"&gt;</content><author><name>strandls</name><uri>http://bioitalliance.org/members/strandls.aspx</uri></author></entry><entry><title>Case Study - Enterprise scale data visualization of pre-clinical data</title><link rel="alternate" type="text/html" href="http://bioitalliance.org/blogs/strandls/archive/2006/10/03/30.aspx" /><link rel="enclosure" type="application/pdf" length="248887" href="http://www.strandls.com/files/PreClinical_data_casestudy.pdf" /><id>http://bioitalliance.org/blogs/strandls/archive/2006/10/03/30.aspx</id><published>2006-10-03T07:19:00Z</published><updated>2006-10-03T07:19:00Z</updated><content type="html">&lt;P&gt;&lt;FONT face=Arial size=2&gt;This case study describes an instance of enterprise-scale data access and visualization using Strand's proprietary technology platform - avadis.&amp;nbsp;It was&amp;nbsp;deployed in a prominent antibody research company in USA.&lt;/FONT&gt;&lt;/P&gt;&lt;img src="http://bioitalliance.org/aggbug.aspx?PostID=30" width="1" height="1"&gt;</content><author><name>strandls</name><uri>http://bioitalliance.org/members/strandls.aspx</uri></author></entry><entry><title>Case Study - Modeling with Neural Networks to predict Mechanism of Action</title><link rel="alternate" type="text/html" href="http://bioitalliance.org/blogs/strandls/archive/2006/10/03/29.aspx" /><link rel="enclosure" type="application/pdf" length="522540" href="http://www.strandls.com/files/MechanismofAction_casestudy.pdf" /><id>http://bioitalliance.org/blogs/strandls/archive/2006/10/03/29.aspx</id><published>2006-10-03T07:16:00Z</published><updated>2006-10-03T07:16:00Z</updated><content type="html">&lt;P&gt;&lt;FONT face=Arial size=2&gt;This study is to showcase a way to predict a drug's mechanism of action from its pattern of activity against a panel of 60 malignant cell lines in the National Cancer Institute's drug screening program.&lt;/FONT&gt;&lt;/P&gt;&lt;img src="http://bioitalliance.org/aggbug.aspx?PostID=29" width="1" height="1"&gt;</content><author><name>strandls</name><uri>http://bioitalliance.org/members/strandls.aspx</uri></author></entry><entry><title>Case Study - Cluster Analysis of Two-Color Data: Human *** Tumor Diversity</title><link rel="alternate" type="text/html" href="http://bioitalliance.org/blogs/strandls/archive/2006/10/03/28.aspx" /><link rel="enclosure" type="application/pdf" length="695383" href="http://www.strandls.com/files/2dye_data_casestudy.pdf" /><id>http://bioitalliance.org/blogs/strandls/archive/2006/10/03/28.aspx</id><published>2006-10-03T07:12:00Z</published><updated>2006-10-03T07:12:00Z</updated><content type="html">&lt;P&gt;&lt;FONT face=Arial size=2&gt;65 surgical specimens of Human&amp;nbsp;*** Tumors from 42 different individuals were studies using c-DNA microarrays representing about 9000 human genes.&lt;/FONT&gt;&lt;/P&gt;&lt;img src="http://bioitalliance.org/aggbug.aspx?PostID=28" width="1" height="1"&gt;</content><author><name>strandls</name><uri>http://bioitalliance.org/members/strandls.aspx</uri></author></entry><entry><title>Case Study - Affymetrix Time Course Data: Myeloid Cell Differentiation</title><link rel="alternate" type="text/html" href="http://bioitalliance.org/blogs/strandls/archive/2006/10/03/27.aspx" /><link rel="enclosure" type="application/pdf" length="499835" href="http://www.strandls.com/files/Affymetrix_Time_Course_Data_Analysis.pdf" /><id>http://bioitalliance.org/blogs/strandls/archive/2006/10/03/27.aspx</id><published>2006-10-03T05:59:00Z</published><updated>2006-10-03T05:59:00Z</updated><content type="html">&lt;P&gt;&lt;FONT face=Arial size=2&gt;The goal of this study is to identify the cascade of genes expression changes, which occur in the MPRO mouse cell line.&lt;/FONT&gt;&lt;/P&gt;&lt;img src="http://bioitalliance.org/aggbug.aspx?PostID=27" width="1" height="1"&gt;</content><author><name>strandls</name><uri>http://bioitalliance.org/members/strandls.aspx</uri></author></entry></feed>